Clinical trials in paediatric populations still pose several challenges and often many studies remain un- published. 10 years on from the introduction of EU Paediatric Investigation Plans (PIPs) there are still many lessons to be learned about the planning and execution of trials which should be tailored around the needs of children. Recent advancements in immuno-oncology research has led to an increase in clinical trials to treat cancer in children and adolescents. Greater emphasis has also been placed on pain-free administration of drugs in the bid to increase vaccination uptake and access to medicines.
Join us as we discuss current clinical trials and the innovative digital technology being used to improve clinical recruitment and retention as well as improve the quality of data being collected. leading industry experts will be looking at how to work within regulations and foster the involvement of young people in their care. We will also be looking at the planning and executing a paediatric clinical trial and the ways this can vary according to region. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.
Reasons to attend Paediatric Clinical Trials 2018
Regulatory keynote from the MHRA - The UK's Early Access to Medicines Scheme (EAMS) and how this scheme benefits paediatric patients
Hear from Amgen and Roche as they give exclusive case studies on new approaches to recruitment, retention, and clinical trial design for rare diseases
Pfizer and Barcelona Children’s Hospital will be exploring how advancements in technology are facilitating improved clinical trials and data collection for paediatric drug development
AstraZeneca will be reviewing and discussing paediatric clinical trial Legislation in the EU and US
Discover how to optimise your approach to clinical success through global collaboration being discussed by Takeda
Book by 30th November to save GBP 400: GBP 1099.00
Book by 15th December and save GBP 200: GBP 1299.00
ook by 31st January and save GBP 100: GBP 1399.00
Standard: GBP 1499.00
Speakers: Amgen, AstraZeneca, GSK, Health Protection Agency, Kite Pharma, MHRA, Otsuka Europe Development and Commercialisation Ltd, Public Health England, Pfizer Inc., Roche Pharma Schweiz AG, Saint Joan de Deu Research Foundation, Sanofi, Takeda, The Royal Liverpool Children's Hospital trust, UCB Pharma and University of Liverpool